Radioiodine therapy in patient of differentiated thyroid cancer with end-stage renal disease on maintenance hemodialysis: case report with review of literature.

Surgical resection followed by radioactive-iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer (DTC). 131I is normally excreted through kidneys and treatment of patients with end stage renal disease (ESRD) on hemodialysis requires special attention for dosage of 131I, timing of dialysis and radiation safety. We present a case of a post-thyroidectomy patient with ESRD on haemodialysis who required radioactive iodine ablation with review of literature.